JPRN-UMIN000016547已完成2 期
A multi-institutional phase II study on safety and efficacy of dynamic tumor tracking stereotactic radiotherapy for the lung - Phase II study on lung DT-SBRT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) history of radiotherapy to the same area 2) active interstitial pneumonia or pulmonary fibrosis 3) severe diabetes mellitus or collagen disease 4) female who are pregnant or in lactation 5) metal disease which prevents registration of the study 6) other issues which are considered to be inappropriate for the study by the doctors
研究者
相似试验
进行中（未招募）
2 期
A multi center, phase 2 study to Evaluate safety and efficacy of total Neoadjuvant treatment of long courSE radiotherapy followed by cheMotherapy, capecitaBine combined with oxaliplatin (CAPOX) for Locally advanced rEctal cancer(ENSEMBLE-2)JPRN-jRCTs071210143KAGAWA Yoshinori27
招募中
2 期
Study of KTE-X19 in Adult Japanese Subjects with Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJPRN-jRCT2063230095Asou Hiroya21
招募中
1 期
Peptide-coupled Red Blood Cells for the Treatment of Multiple SclerosisRelapsing Remitting Multiple Sclerosis (RRMS)MedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2022-000801-28-ITCellerys AG142
招募中
1 期
Peptide-coupled Red Blood Cells for the Treatment of Multiple SclerosisEUCTR2022-000801-28-DECellerys AG142
招募中
1 期
Peptide-coupled Red Blood Cells for the Treatment of Multiple SclerosisEUCTR2022-000801-28-CZCellerys AG142